Telematics Device for Daily Monitoring of Vital Signs in Cancer

The primary goal of this non-profit single-centre randomized pilot interventional study is to evaluate the acceptability of a daily telemonitoring of five vital parameters (heart rate, respiratory rate, blood oxygenation, blood pressure, and body temperature) using a medical device in advanced cancer patients with relevant cardiovascular and respiratory comorbidities assisted at home. In addition to the standard home care, participants in the intervention group will keep the medical device at home. They will register five vital parameters (heart rate, respiratory rate, blood oxygenation, blood pressure, and body temperature) once a day for eight weeks. Participants belonging to the control group will receive standard home care. The secondary goals of this study include the following: * Analyzing the effect of telemonitoring on patients' quality of life and psychological status. * Observing the possible effects of telemonitoring on the caregiver care burden. * Assessing the possible effects of telemonitoring on the caregiver perceived satisfaction with the home care received. * Comparing the number of physician and nurse home visits and phone calls between the patients using the device and patients in standard home care. * Comparing the number of emergency room visits, admissions, and hospitalization days between the patients using the device and patients in standard home care.